CDCES Medications Exam questions with
correct answers
What |diabetes |medications |can |contribute |to |weight |loss? |- |CORRECT |ANSWER✔✔-GLP-1, |
SGLT-2, |Amylin |Mimetic
What |meds |should |be |avoided |in |patients |with |CHF? |- |CORRECT |ANSWER✔✔-Actose/Avandia-
|TZD
Biguanides
What |is |the |action? |- |CORRECT |ANSWER✔✔-Action: |Decreases |hepatic |glucose |output
What |are |the |names |of |Biguanide |drugs? |- |CORRECT |ANSWER✔✔-Metformin/ |Glucophage
What |are |side |effects |of |Biguanides? |- |CORRECT |ANSWER✔✔-B12 |deficiency, |take |with |meals |
to |avoid |GI |upset |
**dont |use |if |GFR |<30, |if |already |on |metformin |and |GFR |falls |between |30-45, |eval |risk
Who |is |approved |to |use |Biguanides? |- |CORRECT |ANSWER✔✔-Approved |in |peds |10years |+ |and
|adults
Sulfonylureas
Action |- |CORRECT |ANSWER✔✔-Stimulates |sustained |insulin |release |by |pancreas
What |are |the |names |of |the |Sulfonylureas? |- |CORRECT |ANSWER✔✔-Glyburide |(Diabeta)
, Glipizide |(Glucotrol,. |Glucotrol |XL)
| Glimepiride |(Amaryl)
Side |effects |of |Sulfonylureas? |- |CORRECT |ANSWER✔✔-Weight |Gain
Hypoglycemia
What |is |the |duration |of |Sulfonlyureas? |- |CORRECT |ANSWER✔✔-12-24hrs
SGLT2 |inhibitors/ |Glucoretics, |What |is |the |action? |- |CORRECT |ANSWER✔✔-Decreases |glucose |
reabsorption |in |the |kidney. |It |brings |the |threshold |of |the |kidney |back |to |180mg/dl, |so |the |
kidney |begins |to |excrete |excess |glucose |earlier |(at |180 |vs |220mg/dl)
What |are |the |names |of |the |SGLT2 |inhibitors/ |Glucoretics? |- |CORRECT |ANSWER✔✔-
Canagliflozin |(Invokana)
Dapagliflozin |(Farxiga)
| Empagliflozin |(Jardiance)
Ertugliflozin |(Steglatro)
What |are |side |effects |of |SGLT2 |inhibitors/ |Glucoretics? |- |CORRECT |ANSWER✔✔-Hypotension
UTI
KETOACIDOSIS
What |are |benefits |of |SGLT2 |inhibitors/ |Glucoretics? |- |CORRECT |ANSWER✔✔-Weight |loss |,
no |hypoglycemia |
can |reduce |risk |of |CV |death |and |preserve |long |term |kidney |function
correct answers
What |diabetes |medications |can |contribute |to |weight |loss? |- |CORRECT |ANSWER✔✔-GLP-1, |
SGLT-2, |Amylin |Mimetic
What |meds |should |be |avoided |in |patients |with |CHF? |- |CORRECT |ANSWER✔✔-Actose/Avandia-
|TZD
Biguanides
What |is |the |action? |- |CORRECT |ANSWER✔✔-Action: |Decreases |hepatic |glucose |output
What |are |the |names |of |Biguanide |drugs? |- |CORRECT |ANSWER✔✔-Metformin/ |Glucophage
What |are |side |effects |of |Biguanides? |- |CORRECT |ANSWER✔✔-B12 |deficiency, |take |with |meals |
to |avoid |GI |upset |
**dont |use |if |GFR |<30, |if |already |on |metformin |and |GFR |falls |between |30-45, |eval |risk
Who |is |approved |to |use |Biguanides? |- |CORRECT |ANSWER✔✔-Approved |in |peds |10years |+ |and
|adults
Sulfonylureas
Action |- |CORRECT |ANSWER✔✔-Stimulates |sustained |insulin |release |by |pancreas
What |are |the |names |of |the |Sulfonylureas? |- |CORRECT |ANSWER✔✔-Glyburide |(Diabeta)
, Glipizide |(Glucotrol,. |Glucotrol |XL)
| Glimepiride |(Amaryl)
Side |effects |of |Sulfonylureas? |- |CORRECT |ANSWER✔✔-Weight |Gain
Hypoglycemia
What |is |the |duration |of |Sulfonlyureas? |- |CORRECT |ANSWER✔✔-12-24hrs
SGLT2 |inhibitors/ |Glucoretics, |What |is |the |action? |- |CORRECT |ANSWER✔✔-Decreases |glucose |
reabsorption |in |the |kidney. |It |brings |the |threshold |of |the |kidney |back |to |180mg/dl, |so |the |
kidney |begins |to |excrete |excess |glucose |earlier |(at |180 |vs |220mg/dl)
What |are |the |names |of |the |SGLT2 |inhibitors/ |Glucoretics? |- |CORRECT |ANSWER✔✔-
Canagliflozin |(Invokana)
Dapagliflozin |(Farxiga)
| Empagliflozin |(Jardiance)
Ertugliflozin |(Steglatro)
What |are |side |effects |of |SGLT2 |inhibitors/ |Glucoretics? |- |CORRECT |ANSWER✔✔-Hypotension
UTI
KETOACIDOSIS
What |are |benefits |of |SGLT2 |inhibitors/ |Glucoretics? |- |CORRECT |ANSWER✔✔-Weight |loss |,
no |hypoglycemia |
can |reduce |risk |of |CV |death |and |preserve |long |term |kidney |function
